Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.
1:16-cv-00237
Overview
Parties
Defendant
Fresenius Kabi USA, LLC Operating Company
Represented By
2 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Counter Claimant
Maia Pharmaceuticals, Inc. Operating Company
Represented By
5 Attorneys ListedSchiff Hardin LLP
666 Fifth Avenue, Suite 1700, New York, NY 10103
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Mylan Institutional Inc. v. Fresenius Kabi USA, LLC
Mylan Institutional Inc. v. Fresenius Kabi USA LLC
Mylan Institutional Inc. v. Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.
Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.
Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9006289
Levothyroxine formulations
|
Filed: 2012-08-29
Issued: 2015-04-14
|
Active (5.9 yrs remaining)
+35d PTA
Expires: 2032-10-03
|
|
|
US9168238
Levothyroxine formulations
|
Filed: 2015-03-08
Issued: 2015-10-27
|
Active (8.3 yrs remaining)
Expires: 2035-03-08
|
|
|
US9168239
Levothyroxine formulations
|
Filed: 2015-03-13
Issued: 2015-10-27
|
Active (8.3 yrs remaining)
Expires: 2035-03-13
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
11
Dispositive
11
Granted
0
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings